
Order #: | H3000-UBP |
Unit Size: | 25 µg |
Supplier: | UBPBio, LLC |
restrictions: | Only available in selected countries. |
shipping: | -80°C |
storage: | Dry ice |
Product Subcategory: | Ubiquitin-Proteasome Research |
More information: | Go to webpage |
MoBiTecGmbH是一家私人控股公司,由StephanDiekmann教授于1987年创立。与Max-Planck学会的密切关系以及德国领先的研究中心之一哥廷根的所在地促进了与某些研究中心的密切合作。德国最具创造力的科学家。此外,MoBiTec一直与欧洲和北美的科学家广泛合作,包括法国巴斯德研究所和荷兰Vrije大学的科学家。通过将许多研究人员的精彩创意商业化,MoBiTec能够提供一系列独特的高质量产品和简化的协议,使实验室生活更轻松,并为实际研究留出更多时间。MoBiTec的产品包括e。G。用于体内检测蛋白质-蛋白质或DNA-蛋白质相互作用的双杂交系统,用于筛选特定肽配体的噬菌粒展示系统和选择具有特异性结合特性的新蛋白质,方便的LamBDaPS基因组文库用于克隆的多功能DNA载体,表达和分析靶基因,有效表达和纯化重组蛋白的试剂盒,细胞转染试剂和细胞培养工具,固定化和可溶性酶,许多用于基因组学和蛋白质组学研究的产品(例如用于PCR,核酸和蛋白质纯化和分析),众多抗体,细胞因子,生长因子和重组蛋白,优质荧光试剂和试剂盒(如蛋白标记试剂盒,标记抗体,细胞染色试剂,柱和凝胶电泳附件)。与其自有产品线并行,MoBiTec分销德国多家国际公司的产品,包括荧光探针和研究化学品(AnaSpec,TEFLabs),量子点,各种DNA纯化试剂盒和DNA聚合酶(EdgeBio),诊断工具(ZJBioTech)),凝胶电泳配件(Amresco,ClareChemical),糖生物学产品(DextraLaboratories,Sumitomo),细胞转染试剂(Mirus)以及抗体,蛋白质,底物,精细化学品和分子和细胞生物学试剂盒 -特别是病毒学,免疫学,神经生物学,细胞凋亡,信号转导,细胞增殖,细胞毒性和癌症研究(MBLI,AGScientific,Amresco,AdarBiotech,AnaSpec,Echelon)。MoBiTec提供全面的服务,从清晰完整的产品文档开始,为客户提供个性化的建议和技术服务。MoBiTec产品通过MoBiTec的总部在德国分销,在其他国家由分销商分销。此外,MoBiTec不断寻求新产品和可销售的许可技术,因此对科学合作非常感兴趣,以开发创新的产品理念。
MoBiTec拥有来自欧洲和北美的研究人员,包括法国的Pasteur研究中心和荷兰的Vrije大学的科学家。MoBiTec公司能提供独一无二的高质量产品,从而简化实验设计,而留出更多更宝贵的时间用于实际的研究。产品包括:双杂交和单杂交系统——体内蛋白-蛋白和DNA-蛋白关系,噬菌体展示系统——筛选特殊的多肽配体和选择具有特异性结合特性的新的蛋白质,LamdaPS基因文库,用于克隆的多功能DNA载体,靶基因的表达与分析,重组蛋白质高效表达和纯化试剂盒,细胞转染试剂和细胞培养工具,各种固体和溶解状态的酶,基因组学和蛋白组学研究产品(PCR,核酸,蛋白质纯化分析),各种抗体、细胞因子、生长因子、重组蛋白质,高级荧光试剂和试剂盒(蛋白质标记试剂盒,标记抗体,细胞染色试剂,钙指示器),亲和层析仪,凝胶分析工具——凝胶柱和凝胶电泳附件。
ebiomall.com






>
>
>
>
>
>
>
>
>
>
>
>
不加磷酸化抑制剂也可以做磷酸化蛋白WB,但是有可能会影响具体的实验结果,大部分时候不加磷酸化抑制剂也能得到结果的。
需要注意蛋白的磷酸化是一个非常迅速的反应,所以取样品的过程要迅速,样品要新鲜。
所以做磷酸化蛋白WB,提取蛋白时不加磷酸酶抑制剂会有影响
酶抑制剂新药发现的途径:一是来源于天然化合物,包括动植物和各种微生物等,二是化学合成物。在目前上市的药物中,以受体为作用靶点的药物占52%,以酶为靶点的药物占22%,以离子通道为靶点的药物占6%,以核酸为靶点的药物占3%。因此,酶抑制剂的开发是新药来源的一个主要途径。以酶为靶点开发新药存在巨大潜力,今后很长一段时间仍然是发现新药的重要着手点。
Author:Shih IeM, Wang TL.
Resource:Cancer Res. 2007 Mar 1;67(5):1879-82.
Impact Factor:8.0(2005)
Abstract:The Notch signaling pathway represents a critical component in the molecular circuits that control cell fate during development. Aberrant activation of this pathway contributes to tumorigenesis. The role of Notch in human cancer has been highlighted recently by the presence of activating mutations and amplification of Notch genes in human cancer and by the demonstration that genes in the Notch signaling pathway could be potential therapeutic targets. It has become clear that one of the major therapeutic targets in the Notch pathway are the Notch receptors, in which gamma-secretase inhibitors prevent the generation of the oncogenic (intracellular) domain of Notch molecules and suppress the Notch activity. This review article summarizes the biological roles of Notch molecules in cancer development with special emphasis on the promise and challenges in applying gamma-secretase inhibitors as a new line of targeted therapeutic agents.
PMID: 17332312
A9 B12 C17 D36
正确答案C
一次氧化的产物不是乙酰COA么,那么产生的ATP为什么不是十个
请根据自己专业背景选择认领,如使用翻译软件翻译,被发现者扣分1-2分
新近参与本次活动的会员请查看:http://news.dxy.cn/bbs/topic/21537141
寻找最近的翻译贴请查看:
http://search.dxy.cn/?words=%E8%B5%84%E8%AE%AF%E7%BF%BB%E8%AF%91&bid=116&t=1&c=1&age=7&bid=116&limit=30&o=1
翻译时请参照版规科技动态版版规及加分细则(2014-02-21更新)-蚂蚁淘论坛
本文题目仅供译者参考,篇幅较长者可适当延时
为保证翻译质量,每人最多认领两篇
Exercisedampensaromataseinhibitor–relatedjointpain
http://www.internalmedicinenews.com/specialty-focus/oncology-hematology/single-article-page/exercise-dampens-aromatase-inhibitor-related-joint-pain/33383ff19a0cd42399a7cf8590708ebf.html
SANANTONIO–Adoptingastandardexerciseprogramresultedinaclinicallymeaningful30%reductioninaromataseinhibitor-associatedjointpaininbreastcancerpatientswhoparticipatedinayear-longrandomizedtrial.
TheexerciseprescriptionutilizedintheHOPE(HormonesandPhysicalExercise)trialwaswhat’srecommendedinnationalguidelinesbothforcancersurvivorsandhealthyadults:150minutesperweekofatleastmoderate-intensityaerobicactivity,suchasbriskwalking,alongwithtwostrength-trainingsessionsperweek,MelindaL.Irwin,Ph.D.,explainedattheSanAntonioBreastCancerSymposium.
TheHOPEstudiesenrolled121postmenopausalwomenwhohadstage1-3,hormonereceptor–positivebreastcancersandwerephysicallyinactiveandoverweightyetphysicallyabletoexercise.Atenrollment,theywereexperiencingmoderatearomataseinhibitor(AI)–associatedjointpain,definedasascoreof5-7onthe0-10BriefPainInventory(BPI),afterabout18monthsonthemedication.Roughlytwo-thirdsofparticipantshadnohistoryofjointpainpriortostartingAItherapy;therestreportedtheAIexacerbatedtheirpreexistingjointpain.Subjectswererandomizedtotheexerciseprogramortousualcare,whichincludedwritteninformationabouttheimportanceofexercise.
Theprimarystudyendpointwasthe12-monthchangeinBPIworstpainscore,whichdroppedbyanaverageof30%amongtheexercisegroup.Thistranslatedtoanimprovementinpainlevelfrommoderateatbaselinetomildatfollow-up.Inaddition,BPIscoresratingpainseverityandpaininterferenceimprovedbyabout20%.Incontrast,patientsintheusualcarecontrolgroupexperiencedaslightincreaseinBPIscoresinallthreedomainsovertime,addedDr.Irwin,co-leaderofthecancerpreventionandcontrolresearchprogramatYaleUniversityCancerCenter,NewHaven,Conn.
TheHOPEresultsreceivedanenthusiasticaudiencereception.Physicianswereparticularlyimpressedwiththe70%exerciseadherencerateoverthecourseofayear.Theyaskedhowtheycankeeptheirpreviouslysedentarypatients’commitmenttoregularexercisefromwaningafteraninitialburstofenthusiasm,assooftenhappens.
Dr.Irwinrepliedthatadherencetolifestylechangeisalwaysachallenge.Socialsupportisquitehelpful.TheexercisegroupinHOPEreceivedapaidgymmembershipandmetinsmallgroupswithapersonaltrainertwiceweekly.
"Thewomenreallybondedwitheachother.Andtherearenowagrowingnumberoffreeprogramsthroughoutthecountry,whichgivecancersurvivorsastartonanexerciseprogramwithafreegymmembershipforseveralmonths.Forexample,theLivestrongFoundationhaspartneredwiththeYMCAtoofferfreeexerciseprogramsforcancersurvivorsatlocalYs,"shesaid.
TheHOPEtrialwasfundedbytheNationalCancerInstitute.Dr.Irwinreportedhavingnofinancialconflictsofinterest.
Thisdegreeofimprovementinjointpainisgreaterthanreportedinstudiesofglucosamine,acupuncture,orvitaminDsupplementation,shenoted.
Theimprovementinpainscoresintheexercisegroupwasgreaterat12monthsthanat3or6,suggestingthatayear-longexerciseprogramisprobablynecessarytoseesustainedreductioninjointpain.
At12monthsoffollow-up,womenintheexercisegroupaveraged159minutesofphysicalactivityperweek,110minutesmorethancontrols.Compliancewiththesupervisedexerciseprogramwasnotablygood,withwomenattendinganaverageof70%ofthetwice-weeklysmall-groupstrength-trainingsessions.
InadditiontotheimprovementinAI-relatedarthralgias,theexercisegroupexperiencedancillarybenefits:amean6.5%improvementinpeakoxygenconsumption,orVO2max,comparedwithbaseline,alongwitha3%reductioninbodyweight.
HOPEwasthefirstrandomizedtrialtoexaminetheeffectsofexerciseonAIsideeffectsinbreastcancerpatients.TheimpetusforthestudywastherecognitionthatarthralgiasarethemostcommonreasonforpooradherencetoanddiscontinuationofAItherapy.Upto20%ofbreastcancerpatientsdiscontinuetheirAIwithinthefirstyear.Andbothearlydiscontinuationandpooradherencehavebeenshowntobepredictiveofincreasedmortalityrisk.

